Diadema Partners »

Cellectar Biosciences shares owned by Diadema Partners

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $385k 138k 2.78

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Cellectar Biosciences

Caligan Partners
Stempoint Capital
Vanguard Capital Management
Silverarc Capital Management
Bleichroeder
Jupiter Topco
Balyasny Asset Management
Nantahala Capital Management
Empery Asset Management
Diadema Partners
Stonepine Capital Management
Persistent Asset Partners
Boothbay Fund Management
Geode Capital Management
Vanguard Fiduciary Trust

View all funds holding Cellectar Biosciences